Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00075686
Other study ID # CDR0000347414
Secondary ID S0205CALGB-S0205
Status Completed
Phase Phase 3
First received January 9, 2004
Last updated November 16, 2015
Start date January 2004
Est. completion date April 2009

Study information

Verified date November 2015
Source Southwest Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Federal GovernmentUnited States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies, such as cetuximab, can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether gemcitabine is more effective with or without cetuximab in treating pancreatic cancer.

PURPOSE: This randomized phase III trial is studying giving gemcitabine together with cetuximab to see how well it works compared to giving gemcitabine alone as first-line therapy in treating patients with locally advanced unresectable or metastatic adenocarcinoma of the pancreas.


Description:

OBJECTIVES:

- Compare the overall survival of patients with locally advanced unresectable or metastatic adenocarcinoma of the pancreas treated with gemcitabine and cetuximab vs gemcitabine alone.

- Compare the time to treatment failure in patients treated with these regimens.

- Estimate the percentage of patients with epidermal growth factor receptor (EGFR) tumor expression in patients treated with these regimens.

- Compare the overall survival of patients in the EGFR-positive subset treated with these regimens.

- Compare the toxicity of these regimens in these patients.

- Compare the total response rate (confirmed and unconfirmed complete and partial response) in patients with measurable disease treated with these regimens.

- Compare the patient report of pain and quality of life of patients treated with these regimens.

OUTLINE: This is an open-label, randomized, multicenter study. Patients are stratified according to disease status (locally advanced unresectable vs metastatic), Zubrod performance status (0 or 1 vs 2), and prior pancreatectomy (yes vs no). Patients are randomized to 1 of 2 treatment arms.

- Arm I: Patients receive cetuximab IV over 1-2 hours on days 1, 8, 15, and 22 and gemcitabine IV over 30 minutes on days 1, 8, 15, and 22 for course 1 and days 1, 8, and 15 for all subsequent courses.

- Arm II: Patients receive gemcitabine as in arm I. In both arms, courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline, before each course, and at the end of study therapy.

Patients are followed every 6 months for 2 years and then annually for 1 year.

PROJECTED ACCRUAL: A total of 704 patients (352 per treatment arm) will be accrued for this study within 5 years.


Recruitment information / eligibility

Status Completed
Enrollment 766
Est. completion date April 2009
Est. primary completion date May 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS:

- Histologically* or cytologically confirmed pancreatic adenocarcinoma meeting 1 of the following criteria:

- Locally advanced unresectable disease

- Distant metastatic disease NOTE: If diagnosis is based on a metastatic site the histology must be compatible with pancreatic cancer

- Measurable or nonmeasurable disease by x-ray, scan, or physical examination

- Tumor tissue must be submitted for evaluation of epidermal growth factor receptor expression before study entry

- None of the following tumor types are allowed:

- Endocrine tumors

- Lymphoma of the pancreas

- Ampullary cancer

- No known brain metastases

PATIENT CHARACTERISTICS:

Age

- Not specified

Performance status

- Zubrod 0-2

Life expectancy

- At least 3 months

Hematopoietic

- Absolute granulocyte count at least 1,500/mm^3

- Platelet count at least 100,000/mm^3

Hepatic

- Bilirubin no greater than 2.0 times upper limit of normal (ULN)

- SGOT or SGPT no greater than 2.5 times ULN

Renal

- Creatinine no greater than 2.0 mg/dL

Cardiovascular

- No significant history of cardiac disease

- No uncontrolled hypertension

- No unstable angina

- No uncontrolled arrhythmia

- No congestive heart failure

Other

- Not pregnant or nursing

- Fertile patients must use effective contraception

- HIV negative

- No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I or II cancer that is currently in remission

PRIOR CONCURRENT THERAPY:

Biologic therapy

- No prior immunotherapy for advanced pancreatic cancer

- No prior cetuximab or other therapy that targets the epidermal growth factor pathway

- No prior chimerized or murine monoclonal antibody therapy

- No other concurrent anticancer immunotherapy

Chemotherapy

- At least 6 months since prior adjuvant chemotherapy

- No prior chemotherapy or chemoradiotherapy for advanced pancreatic cancer

- No prior gemcitabine

- No other concurrent anticancer chemotherapy

Endocrine therapy

- No prior hormonal therapy for advanced pancreatic cancer

- No concurrent anticancer hormonal therapy

Radiotherapy

- See Chemotherapy

- At least 28 days since prior radiotherapy and recovered

- Prior palliative radiotherapy to metastatic sites allowed

- No concurrent anticancer radiotherapy, including whole brain radiotherapy for progressive disease (i.e., CNS metastasis)

Surgery

- At least 14 days since prior pancreatic cancer surgery and recovered

Other

- No other concurrent anticancer therapy

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
cetuximab
Loading dose: Cetuxiumab 400mg/m2, IV on Day 1 (cycle 1 only). Weekly maintenance: Cetuximab 250mg/m2, IV on Days 8,15,22 of cycle 1 & days 1,8,15,22 of all subsequent cycles
Drug:
gemcitabine hydrochloride
1000mg/m2 IV over 30 minutes

Locations

Country Name City State
Canada Royal Victoria Hospital of Barrie Barrie Ontario
Canada Nova Scotia Cancer Centre Halifax Nova Scotia
Canada Trillium Health Centre - Mississauga Site Mississauga Ontario
Canada Allan Blair Cancer Centre at Pasqua Hospital Regina Saskatchewan
Canada Saint John Regional Hospital Saint John New Brunswick
Canada St. Joseph's Health Centre - Toronto Toronto Ontario
Canada CancerCare Manitoba Winnipeg Manitoba
United States Hickman Cancer Center at Bixby Medical Center Adrian Michigan
United States Akron City Hospital Akron Ohio
United States McDowell Cancer Center at Akron General Medical Center Akron Ohio
United States New York Oncology Hematology, PC - Albany Albany New York
United States University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico
United States Saint Anthony's Hospital at Saint Anthony's Health Center Alton Illinois
United States Harrington Cancer Center Amarillo Texas
United States American Fork Hospital American Fork Utah
United States McFarland Clinic, P. C. Ames Iowa
United States Alaska Regional Hospital Cancer Center Anchorage Alaska
United States Cancer Center at Providence Alaska Medical Center Anchorage Alaska
United States Rose Ramer Cancer Clinic at Anderson Area Medical Center Anderson South Carolina
United States University of Michigan Comprehensive Cancer Center Ann Arbor Michigan
United States Fox Valley Hematology and Oncology - East Grant Street Appleton Wisconsin
United States Randolph Hospital Asheboro North Carolina
United States Mission Hospitals - Memorial Campus Asheville North Carolina
United States Cancer Care at Our Lady of Bellefonte Hospital Ashland Kentucky
United States Sturdy Memorial Hospital Attleboro Massachusetts
United States Auburn Regional Center for Cancer Care Auburn Washington
United States Rush-Copley Cancer Care Center Aurora Illinois
United States University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora Colorado
United States Battle Creek Health System Cancer Care Center Battle Creek Michigan
United States St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove Indiana
United States St. Joseph Hospital Community Cancer Center Bellingham Washington
United States St. Charles Medical Center - Bend Bend Oregon
United States Green Mountain Oncology Group Bennington Vermont
United States Southwestern Vermont Regional Cancer Center Bennington Vermont
United States Alta Bates Comprehensive Cancer Center Berkeley California
United States St. Luke's Hospital Cancer Center Bethlehem Pennsylvania
United States Hematology Oncology Associates of the Quad Cities Bettendorf Iowa
United States Mecosta County Medical Center Big Rapids Michigan
United States CCOP - Montana Cancer Consortium Billings Montana
United States Deaconess Billings Clinic - Downtown Billings Montana
United States Deaconess Billings Clinic Cancer Center Billings Montana
United States Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana
United States Northern Rockies Radiation Oncology Center Billings Montana
United States St. Vincent Healthcare Billings Montana
United States St. Joseph Medical Center Bloomington Illinois
United States Lynn Regional Cancer Center at Boca Raton Community Hospital - Main Center Boca Raton Florida
United States St. Luke's Mountain States Tumor Institute - Boise Boise Idaho
United States Cancer Center of Boston - Chestnut Hill Boston Massachusetts
United States Cancer Research Center at Boston Medical Center Boston Massachusetts
United States Caritas St. Elizabeth's Medical Center Boston Massachusetts
United States Wood County Oncology Center Bowling Green Ohio
United States Bozeman Deaconess Hospital Bozeman Montana
United States Internal Medicine Associates of Bozeman Bozeman Montana
United States Olympic Hematology and Oncology Bremerton Washington
United States Roswell Park Cancer Institute Buffalo New York
United States Peninsula Medical Center Burlingame California
United States Fairview Ridges Hospital Burnsville Minnesota
United States St. James Community Hospital Butte Montana
United States Graham Hospital Canton Illinois
United States University Hospitals Ireland Cancer Center at Mercy Medical Center Canton Ohio
United States Saint Francis Medical Center Cape Girardeau Missouri
United States Memorial Hospital Carthage Illinois
United States Cedar Rapids Oncology Associates Cedar Rapids Iowa
United States Mercy Regional Cancer Center at Mercy Medical Center Cedar Rapids Iowa
United States St. Luke's Hospital Cedar Rapids Iowa
United States Providence Centralia Hospital Regional Cancer Center Centralia Washington
United States Cancer Center of Kansas, P.A. - Chanute Chanute Kansas
United States Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina
United States Roper St. Francis Cancer Center at Roper Hospital Charleston South Carolina
United States Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina
United States Martha Jefferson Hospital Cancer Care Center Charlottesville Virginia
United States Adena Regional Medical Center Chillicothe Ohio
United States Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio
United States United Hospital Center Clarksburg West Virginia
United States Cleveland Clinic Taussig Cancer Center Cleveland Ohio
United States Euclid Hospital Cleveland Ohio
United States Huron Hospital Cancer Care Center Cleveland Ohio
United States Memorial Hospital Colorado Springs Colorado
United States CCOP - Columbus Columbus Ohio
United States Doctors Hospital at Ohio Health Columbus Ohio
United States Grant Riverside Cancer Services Columbus Ohio
United States John B. Amos Community Cancer Center Columbus Georgia
United States Mount Carmel West Hospital Columbus Ohio
United States Riverside Methodist Hospital Cancer Care Columbus Ohio
United States Mount Diablo Regional Cancer Center Concord California
United States Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids Minnesota
United States Heartland Oncology & Hematology Council Bluffs Iowa
United States Medical City Dallas Hospital Dallas Texas
United States Presbyterian Hospital of Dallas Dallas Texas
United States Praxair Cancer Center at Danbury Hospital Danbury Connecticut
United States Danville Regional Medical Center Danville Virginia
United States Genesis Medical Center - West Campus Davenport Iowa
United States Genesis Regional Cancer Center at Genesis Medical Center Davenport Iowa
United States CCOP - Dayton Dayton Ohio
United States Good Samaritan Hospital Dayton Ohio
United States Grandview Hospital Dayton Ohio
United States Samaritan North Cancer Care Center Dayton Ohio
United States Veterans Affairs Medical Center - Dayton Dayton Ohio
United States Halifax Medical Center Daytona Beach Florida
United States Decatur Memorial Hospital Cancer Care Institute Decatur Illinois
United States Grady Memorial Hospital Delaware Ohio
United States Veterans Affairs Medical Center - Denver Denver Colorado
United States Barbara Ann Karmanos Cancer Institute Detroit Michigan
United States Josephine Ford Cancer Center at Henry Ford Hospital Detroit Michigan
United States Cancer Center of Kansas, P.A. - Dodge City Dodge City Kansas
United States Seacoast Cancer Center at Wentworth-Douglass Hospital Dover New Hampshire
United States City of Hope Comprehensive Cancer Center Duarte California
United States Oncology Hematology Associates of Northern Pennsylvania, P.C. at Hahne Regional Cancer Center Dubois Pennsylvania
United States Easton Regional Cancer Center at Easton Hospital Easton Pennsylvania
United States Luther Midlelfort Hospital Eau Claire Wisconsin
United States Midelfort Clinic - Luther Eau Claire Wisconsin
United States John Smith, Jr./Dalton McMichael Cancer Center at Morehead Memorial Hospital Eden North Carolina
United States Fairview Southdale Hospital Edina Minnesota
United States Cancer Center of Kansas, P.A. - El Dorado El Dorado Kansas
United States Center for Cancer Medicine and Blood Disorders, PA El Paso Texas
United States Sherman Hospital Elgin Illinois
United States Vince Lombardi Cancer Center - Elkhorn Elkhorn Wisconsin
United States Eureka Community Hospital Eureka Illinois
United States San Juan Regional Cancer Center Farmington New Mexico
United States St. Francis Hospital Federal Way Washington
United States Blanchard Valley Medical Associates Findlay Ohio
United States McLeod Regional Medical Center Florence South Carolina
United States Front Range Cancer Specialists Fort Collins Colorado
United States Poudre Valley Hospital Fort Collins Colorado
United States Brooke Army Medical Center Fort Sam Houston Texas
United States Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana
United States Fremont Memorial Hospital Fremont Ohio
United States California Cancer Center - Woodward Park Office Fresno California
United States Mercy and Unity Cancer Center at Unity Hospital Fridley Minnesota
United States Broward General Medical Center Cancer Center Ft. Lauderdale Florida
United States Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Ft. Smith Arkansas
United States Virginia K. Crosson Cancer Center at St. Jude Medical Center Fullerton California
United States Northeast Georgia Medical Center Gainesville Georgia
United States University of Florida Shands Cancer Center Gainesville Florida
United States Galesburg Clinic Galesburg Illinois
United States Galesburg Cottage Hospital Galesburg Illinois
United States InterCommunity Cancer Center of Western Illinois Galesburg Illinois
United States Medical and Surgical Specialists, L L C Galesburg Illinois
United States Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital Gape Girardeau Missouri
United States Delnor Community Hospital - Geneva Geneva Illinois
United States Banner Thunderbird Medical Center Glendale Arizona
United States Adirondack Cancer Care - Glens Falls Glens Falls New York
United States Wayne Memorial Hospital, Incorporated Goldsboro North Carolina
United States Wayne Radiation Oncology Goldsboro North Carolina
United States CCOP - Grand Rapids Grand Rapids Michigan
United States Lacks Cancer Center at Saint Mary's Mercy Medical Center Grand Rapids Michigan
United States Metropolitan Hospital Grand Rapids Michigan
United States Spectrum Health Cancer Care - Butterworth Campus Grand Rapids Michigan
United States Big Sky Oncology Great Falls Montana
United States Sletten Regional Cancer Institute Great Falls Montana
United States North Colorado Medical Center Greeley Colorado
United States Marin Cancer Institute at Marin General Hospital Greenbrae California
United States Sutter Health Western Division Cancer Research Group Greenbrae California
United States Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro North Carolina
United States Bon Secours St. Francis Health System Greenville South Carolina
United States CCOP - Greenville Greenville South Carolina
United States Legacy Mount Hood Medical Center Gresham Oregon
United States Mason District Hospital Havana Illinois
United States Saint Rose Hospital Hayward California
United States St. Peter's Hospital Helena Montana
United States Pardee Memorial Hospital Hendersonville North Carolina
United States Hinsdale Hematology Oncology Associates Hinsdale Illinois
United States Holland Community Hospital Holland Michigan
United States Hopedale Medical Complex Hopedale Illinois
United States Baylor University Medical Center - Houston Houston Texas
United States M.D. Anderson Cancer Center at University of Texas Houston Texas
United States Community Oncology Group at Cleveland Clinic Cancer Center Independence Ohio
United States University of Mississippi Medical Center Jackson Mississippi
United States Joliet Oncology Hematology Associates, Limited - West Joliet Illinois
United States Bronson Methodist Hospital Kalamazoo Michigan
United States West Michigan Cancer Center Kalamazoo Michigan
United States Borgess Medical Center Kalamazooaa Michigan
United States Glacier Oncology, PLLC Kalispell Montana
United States Kalispell Medical Oncology Kalispell Montana
United States Kalispell Regional Medical Center Kalispell Montana
United States CCOP - Kansas City Kansas City Missouri
United States Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas
United States Good Samaritan Health Systems Kearney Nebraska
United States Kenton Oncology, Incorporated Kenton Ohio
United States Keesler Medical Center - Keesler Air Force Base Kessler AFB Mississippi
United States Charles F. Kettering Memorial Hospital Kettering Ohio
United States Kewanee Hospital Kewanee Illinois
United States Cancer Center of Kansas, P.A. - Kingman Kingman Kansas
United States Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center Kingsport Tennessee
United States Lenoir Memorial Cancer Center Kinston North Carolina
United States Thompson Cancer Survival Center Knoxville Tennessee
United States Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin
United States La Grange Memorial Hospital La Grange Illinois
United States Wilford Hall Medical Center Lackland AFB Texas
United States Haematology-Oncology Associates of Ohio and Michigan, P.C. Lambertville Michigan
United States Fairfield Medical Center Lancaster Ohio
United States St. Mary Regional Cancer Center Langhorne Pennsylvania
United States New York Oncology Hematology, P.C. Latham New York
United States Central Maine Medical Center Lewiston Maine
United States Central Baptist Hospital Lexington Kentucky
United States Southwest Medical Center Liberal Kansas
United States Lima Memorial Hospital Lima Ohio
United States St. Rita's Medical Center Lima Ohio
United States Logan Regional Hospital Logan Utah
United States Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda California
United States McKee Medical Center Loveland Colorado
United States UMC Southwest Cancer and Research Center Lubbock Texas
United States McDonough District Hospital Macomb Illinois
United States Medical Center of Central Georgia Macon Georgia
United States CCOP - North Shore University Hospital Manhasset New York
United States Strecker Cancer Center at Marietta Memorial Hospital Marietta Ohio
United States Upper Michigan Cancer Center at Marquette General Hospital Marquette Michigan
United States Northwest Ohio Oncology Center Maumee Ohio
United States St. Luke's Hospital Maumee Ohio
United States Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights Ohio
United States Caritas Holy Family Hospital Methuen Massachusetts
United States Saint Anthony Memorial Health Centers Michigan City Indiana
United States Middletown Regional Hospital Middletown Ohio
United States MidMichigan Medical Center - Midland Midland Michigan
United States Eastern Montana Cancer Center Miles City Montana
United States Medical Consultants, Limited Milwaukee Wisconsin
United States Providence Milwaukie Hospital Milwaukie Oregon
United States Virginia Piper Cancer Institute at Abbott-Northwestern Hospital Minneapolis Minnesota
United States Community Medical Center Missoula Montana
United States Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana
United States Montana Cancer Specialists at Montana Cancer Center Missoula Montana
United States Mobile Infirmary Medical Center Mobile Alabama
United States Community Cancer Center of Monroe Monroe Michigan
United States Mercy Memorial Hospital System Monroe Michigan
United States Montrose Memorial Hospital Cancer Center Montrose Colorado
United States Good Samaritan Regional Health Center Mt. Vernon Illinois
United States Skagit Valley Hospital Cancer Care Center Mt. Vernon Washington
United States Cottonwood Hospital Medical Center Murray Utah
United States Hackley Hospital Muskegon Michigan
United States Long Island Jewish Medical Center New Hyde Park New York
United States Licking Memorial Cancer Care Program at Licking Memorial Hospital Newark Ohio
United States Cancer Center of Kansas, P.A. - Newton Newton Kansas
United States BroMenn Regional Medical Center Normal Illinois
United States Community Cancer Center Normal Illinois
United States Southwest Virginia Regional Cancer Center Norton Virginia
United States Caritas Norwood Hospital Norwood Massachusetts
United States CCOP - Bay Area Tumor Institute Oakland California
United States Highland General Hospital at St. George's University School of Medicine Oakland California
United States Summit Medical Center Oakland California
United States McKay-Dee Hospital Center Ogden Utah
United States Capital Medical Center Olympia Washington
United States Providence St. Peter Hospital Regional Cancer Center Olympia Washington
United States Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields Olympia Fields Illinois
United States Methodist Cancer Center at Methodist Hospital - Omaha Omaha Nebraska
United States East Alabama Medical Center Opelika Alabama
United States Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange California
United States Florida Oncology Associates Orange Park Florida
United States Toledo Clinic - Oregon Oregon Ohio
United States Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando Florida
United States Community Hospital of Ottawa Ottawa Illinois
United States Oncology Hematology Associates of Central Illinois - Ottawa Ottawa Illinois
United States Ottumwa Regional Health Center Cancer Center Ottumwa Iowa
United States Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital Parkersburg West Virginia
United States Cancer Center of Kansas, P.A. - Parsons Parsons Kansas
United States Cancer Treatment Center at Pekin Hospital Pekin Illinois
United States West Florida Cancer Institute at West Florida Hospital - Pensacola Pensacola Florida
United States CCOP - Illinois Oncology Research Association Peoria Illinois
United States Methodist Medical Center of Illinois Peoria Illinois
United States Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois
United States OSF St. Francis Medical Center Peoria Illinois
United States Proctor Hospital Peoria Illinois
United States Illinois Valley Community Hospital Peru Illinois
United States Northern Michigan Hospital Petoskey Michigan
United States Banner Good Samaritan Medical Center Phoenix Arizona
United States CCOP - Western Regional, Arizona Phoenix Arizona
United States Mount Carmel Regional Cancer Center Pittsburg Kansas
United States Allegheny Cancer Center at Allegheny General Hospital Pittsburgh Pennsylvania
United States Valley Care Medical Center Pleasanton California
United States St. Joseph Mercy Hospital Pontiac Michigan
United States CCOP - Columbia River Oncology Program Portland Oregon
United States Institute of Oncology at Vilnius University Portland Oregon
United States Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center Portland Oregon
United States Mercy Hospital Portland Maine
United States Providence Cancer Center at Providence Portland Medical Center Portland Oregon
United States Providence St. Vincent Medical Center Portland Oregon
United States Cancer Center of Kansas, P.A. - Pratt Pratt Kansas
United States Perry Memorial Hospital Princeton Illinois
United States Utah Valley Regional Medical Center - Provo Provo Utah
United States Good Samaritan Cancer Center Puyallup Washington
United States All Saints Cancer Center at All Saints Medical Center Racine Wisconsin
United States Reading Hospital and Medical Center Reading Pennsylvania
United States Annie Penn Cancer Center Reidsville North Carolina
United States Reid Hospital & Health Care Services, Incorporated Richmond Indiana
United States Valley Hospital - Ridgewood Ridgewood New Jersey
United States Hubert H. Humphrey Cancer Center at North Memorial Medical Center Robbinsdale Minnesota
United States William Beaumont Hospital - Royal Oak Campus Royal Oak Michigan
United States Rutherford Hospital Rutherfordton North Carolina
United States Mercy General Hospital Sacramento California
United States University of California Davis Cancer Center Sacramento California
United States Dixie Regional Medical Center - East Campus Saint George Utah
United States David C. Pratt Cancer Center at St. John's Mercy Saint Louis Missouri
United States CCOP - Metro-Minnesota Saint Louis Park Minnesota
United States Salem Hospital Regional Cancer Center Salem Oregon
United States Cancer Center of Kansas, P.A. - Salina Salina Kansas
United States LDS Hospital Salt Lake City Utah
United States Utah Cancer Specialists at UCS Cancer Center Salt Lake City Utah
United States California Pacific Medical Center - California Campus San Francisco California
United States J.C. Robinson, M.D. Regional Cancer Center San Pablo California
United States Firelands Regional Medical Center Sandusky Ohio
United States North Coast Cancer Care, Incorporated Sandusky Ohio
United States Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia
United States Fred Hutchinson Cancer Research Center Seattle Washington
United States Group Health Central Hospital Seattle Washington
United States Harborview Medical Center Seattle Washington
United States Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington
United States University Cancer Center at University of Washington Medical Center Seattle Washington
United States North Puget Oncology at United General Hospital Sedro-Wooley Washington
United States Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming
United States Cancer Treatment Center at Christus Schumpert St. Mary Place Shreveport Louisiana
United States Mercy Medical Center - Sioux City Sioux City Iowa
United States Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center Sioux City Iowa
United States Siouxland Regional Cancer Center Sioux City Iowa
United States St. Luke's Regional Medical Center Sioux City Iowa
United States Avera Cancer Institute Sioux Falls South Dakota
United States Medical X-Ray Center, PC Sioux Falls South Dakota
United States Sioux Valley Hospital and University of South Dakota Medical Center Sioux Falls South Dakota
United States CCOP - Upstate Carolina Spartanburg South Carolina
United States Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina
United States Cancer Care Northwest - Spokane South Spokane Washington
United States Providence Cancer Center at Holy Family Hospital Spokane Washington
United States Providence Cancer Center at Sacred Heart Medical Center Spokane Washington
United States Rockwood Clinic Cancer Treatment Center Spokane Washington
United States St. Margaret's Hospital Spring Valley Illinois
United States Valley Cancer Center Spring Valley Illinois
United States Highlands Oncology Group - Springdale Springdale Arkansas
United States CCOP - Cancer Research for the Ozarks Springfield Missouri
United States Community Hospital of Springfield and Clark County Springfield Ohio
United States Hulston Cancer Center at Cox Medical Center South Springfield Missouri
United States Mercy Medical Center Springfield Ohio
United States Regional Cancer Center at Memorial Medical Center Springfield Illinois
United States St. John's Regional Health Center Springfield Missouri
United States CCOP - St. Louis-Cape Girardeau St. Louis Missouri
United States St. Anthony's Cancer Center St. Louis Missouri
United States Park Nicollet Health Services St. Louis Park Minnesota
United States United Hospital St. Paul Minnesota
United States Carl and Dorothy Bennett Cancer Center at Stamford Hospital Stamford Connecticut
United States Iredell Memorial Hospital Statesville North Carolina
United States Promedica Cancer Center at Flower Hospital Sylvania Ohio
United States CCOP - Hematology-Oncology Associates of Central New York Syracuse New York
United States St. Joseph's Hospital Health Center - Syracuse Syracuse New York
United States Allenmore Hospital Tacoma Washington
United States CCOP - Northwest Tacoma Washington
United States MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma Washington
United States St. Clare Hospital Tacoma Washington
United States St. Joseph Medical Center at Franciscan Health System Tacoma Washington
United States CCOP - Toledo Community Hospital Toledo Ohio
United States Medical College of Ohio Cancer Institute Toledo Ohio
United States St. Vincent Mercy Medical Center Toledo Ohio
United States Toledo Clinic, Incorporated - Main Clinic Toledo Ohio
United States Toledo Hospital Toledo Ohio
United States Toledo Surgical Specialists Toledo Ohio
United States St. Francis Comprehensive Cancer Center Topeka Kansas
United States Stormont-Vail Cancer Center Topeka Kansas
United States Munson Medical Center Traverse City Michigan
United States UVMC Cancer Care Center at Upper Valley Medical Center Troy Ohio
United States Legacy Meridian Park Hospital Tualatin Oregon
United States Carle Cancer Center at Carle Foundation Hospital Urbana Illinois
United States CCOP - Carle Cancer Center Urbana Illinois
United States Faxton Regional Cancer Center Utica New York
United States Pearlman Comprehensive Cancer Center at South Georgia Medical Center Valdosta Georgia
United States Sutter Solano Medical Center Vallejo California
United States Southwest Washington Medical Center Cancer Center Vancouver Washington
United States Ridgeview Medical Center Waconia Minnesota
United States John Muir/Mt. Diablo Comprehensive Cancer Center Walnut Creek California
United States South Pointe Hospital Cancer Care Center Warrensville Heights Ohio
United States Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington District of Columbia
United States Sibley Memorial Hospital Washington District of Columbia
United States Cedar Valley Medical Specialists, P.C. - West Ridgeway Avenue Waterloo Iowa
United States Covenant Cancer Treatment Center Waterloo Iowa
United States Fulton County Health Center Wauseon Ohio
United States Cancer Center of Kansas, P.A. - Wellington Wellington Kansas
United States Wenatchee Valley Clinic Wenatchee Washington
United States Jennersville Regional Hospital West Grove Pennsylvania
United States Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital Westerville Ohio
United States Exempla Lutheran Medical Center Wheat Ridge Colorado
United States Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital Whittier California
United States Associates in Womens Health, P.A. - North Review Wichita Kansas
United States Cancer Center of Kansas, P.A. - Medical Arts Tower Wichita Kansas
United States Cancer Center of Kansas, P.A. - Wichita Wichita Kansas
United States CCOP - Wichita Wichita Kansas
United States Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas
United States Wilson Medical Center Wilson North Carolina
United States Cancer Center of Kansas, P.A. - Winfield Winfield Kansas
United States Forsyth Regional Cancer Center at Forsyth Medical Center Winston-Salem North Carolina
United States Cleveland Clinic - Wooster Wooster Ohio
United States United States Air Force Medical Center Wright-Patterson Wright-Patterson Afb Ohio
United States Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia Ohio
United States Tod Children's Hospital - Forum Health Youngstown Ohio
United States Genesis - Good Samaritan Hospital Zanesville Ohio

Sponsors (4)

Lead Sponsor Collaborator
Southwest Oncology Group Canadian Cancer Trials Group, Cancer and Leukemia Group B, National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Canada, 

References & Publications (1)

Philip PA, Benedetti J, Fenoglio-Preiser C, et al.: Phase III study of gemcitabine [G] plus cetuximab [C] versus gemcitabine in patients [pts] with locally advanced or metastatic pancreatic adenocarcinoma [PC]: SWOG S0205 study. [Abstract] J Clin Oncol 25

Outcome

Type Measure Description Time frame Safety issue
Primary Overall survival comparison between treatment groups every 4 weeks for 3 years No
Secondary Response rate comparison between treatment groups as measured by RECIST and radiological evaluation at every other course every 9 weeks until progression No
Secondary Time to treatment failure comparison between groups from registration to first observation of progressive disease, symptomatic deterioration, or death every 4 weeks while on treatment No
Secondary Percentage of patients with EGFR tumor expression and compare overall survival of patients in the EGFR subset every 4 weeks for 3 years No
Secondary Toxicity profile comparison of patients treated with 2 regimens and measured until 30 days after completion of study treatment every 4 weeks while on treatment Yes
Secondary Total response rate comparison between treatment groups in the subset of patients with measurable disease by RECIST at every other course every 9 weeks until progression No
Secondary Pain and quality of life comparison between treatment groups as measured by patient questionnaire at baseline, before each course, and then completion of study treatment every 4 weeks while on treatment No
See also
  Status Clinical Trial Phase
Completed NCT05305001 - Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico
Completed NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Recruiting NCT05497531 - Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers N/A
Recruiting NCT04927780 - Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer Phase 3
Recruiting NCT06054984 - TCR-T Cells in the Treatment of Advanced Pancreatic Cancer Early Phase 1
Recruiting NCT05919537 - Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation Phase 1
Terminated NCT03140670 - Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy Phase 2
Terminated NCT00529113 - Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer Phase 1
Recruiting NCT05168527 - The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients Phase 2
Active, not recruiting NCT04383210 - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Phase 2
Recruiting NCT05391126 - GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care N/A
Terminated NCT03300921 - A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer Phase 1
Completed NCT03153410 - Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas Early Phase 1
Recruiting NCT03175224 - APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Phase 2
Recruiting NCT05679583 - Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer Phase 2
Recruiting NCT04183478 - The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer Phase 2/Phase 3
Terminated NCT03600623 - Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer Early Phase 1
Recruiting NCT04584008 - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics N/A
Recruiting NCT05351983 - Patient-derived Organoids Drug Screen in Pancreatic Cancer N/A
Completed NCT04290364 - Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study